FRED HUTCHINSON CANCER CENTER
๐บ๐ธUnited States
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
Phase 1
Completed
- Conditions
- Autoimmune DiseasesSystemic SclerosisDermatomyositisSystemic Lupus ErythematosusJuvenile Rheumatoid Arthritis
- Interventions
- Procedure: Stem Cell TransplantationDevice: CD34 selection
- First Posted Date
- 2001-02-02
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00010335
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
Not Applicable
Completed
- Conditions
- Metabolism, Inborn ErrorsGranulomatous Disease, Chronic
- First Posted Date
- 2001-02-02
- Last Posted Date
- 2014-12-09
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00010361
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
Phase 1
Completed
- Conditions
- Adenosine Deaminase DeficiencyAutosomal Recessive DisorderImmune System DisorderPurine-Nucleoside Phosphorylase DeficiencySevere Combined ImmunodeficiencySevere Combined Immunodeficiency With Absence of T and B CellsX-Linked Severe Combined Immunodeficiency
- Interventions
- Procedure: Allogeneic Bone Marrow TransplantationOther: Laboratory Biomarker AnalysisProcedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationRadiation: Total-Body Irradiation
- First Posted Date
- 2001-01-08
- Last Posted Date
- 2019-07-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00008450
- Locations
- ๐บ๐ธ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
Phase 1
Completed
- Conditions
- Sickle Cell Anemia
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2008-09-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT00004485
- Locations
- ๐บ๐ธ
Children's Hospital of Oakland, Oakland, California, United States
๐บ๐ธFred Hutchinson Cancer Research Center, Seattle, Washington, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath